ATG3 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC) patients, the expression level of miR-16 was significantly downregulated, whereas that of ATG3 was upregulated, with the 3’-UTR of ATG3 as the direct target of miR-16 (Wang H. et al., 2018).